Peter Lehmann
Brave New Psychiatry (ebook)
(= Schöne neue Psychiatrie)
A two-volume ebook, that reveals the risks of psychiatric drugs,
on the market in 1996, as well as the risks of electroshocks ruthless
and easy to understand. With advices how to withdraw responsible.
The two-volume publication addresses primary to
the treated persons and their relatives und enables them a grounded
and independent decision: taking psychiatric drugs in spite of
considerable risks for the healthor better not. If already
a damage is done, then the proof should be made easier, that it
was caused by the treatment. Workers in the psychosocial system
can use the book as manual and work of reference.
Antidepressants, lithium, neuroleptics, tranquilizers,
psychostimulants and carbamazepine are given to more and more
human beingsespecially to women, children and the elderlyin
increasing doses and in combinations that have effects not to
calculate. Though a critical knowledge about their dangers is
more important than ever.
A chapter by its own is dedicated to the potential of dependence
on these substances as well as to advices how to come down.
The
Author
Peter Lehmann, D. Phil. h.c. Born in 1950. Education in pedagogy.
Living as independent publisher and author in Berlin. In 1989,
co-founder of the Organisation for the Protection from Psychiatric
Violence, running the Runaway-house
Berlin. In 1991, co-founder of the European
Network of (ex-) Users and Survivors of Psychiatry (ENUSP);
from 1997-1999, Chair of ENUSP; until 2010, board member. In 2010,
awarded with an Honorary
Doctorate in acknowledgement of "exceptional scientific and
humanitarian contribution to the rights of the people with psychiatric
experience" by the School of Psychology of the Aristotle University
of Thessaloniki, Greece, Faculty of Philosophy. In 2011, awarded
the Order of Merit of the Federal Republic of Germany by the President
of Germany. English publications include, Withdrawal
from Prescribed Psychotropic Drugs (edited in 2021 together
with Craig Newnes);
Coming
off Psychiatric Drugs: Successful Withdrawal from Neuroleptics,
Antidepressants, Mood Stabilizers, Ritalin and Tranquilizers
(edited in 2004; ebook
in 2021); Alternatives
beyond Psychiatry, edited together with Peter Stastny
in 2007 (ebook
in 2021). More about Peter
Lehmann
Additional information to "Brave New
Psychiatry"
Tranquilizers (alium etc.), lithium, antidepressants (Prozac
etc.), neuroleptics (Haldol etc.), carbamazepine (Tegretol etc.)
and psychostimulants (Ritalin etc.) are used more and more in
the psychiatric and medical system, especially in the general
medicine and the paediatrics. Since 1985 the trend steadily goes
away from tranquilizers and towards antidepressants and neuroleptics.
In Germany, on average 70% of all psychiatric drugs are administered
to women, with increasing age in rising tendency. Every seventh
psycho-pill is swallowed by children less than twelve years old.
15% of all children and adolescents and 25% of all adults are
considered as mentally disturbed, so they are possible consumers.
Nothing points out that the situation outside of Germany is fundamentally
different.
In general, the treated persons do not receive information about
the probable, the possible and the not-excludable risks. They
do not know, that some substances had to be withdrawn from the
drug-market in the one countries, but are sold without restriction
in the other countries, for example penfluridol (brand name: Semap)
as a possible carcinogen, remoxipride (Roxiam) because of blood
damage, and triazolam (brand names: Halcion, Hypam) in connection
with amnesia and black-outs. If people want to have full information
on the risks, which are connected with the administration of psychiatric
drugs and electroshocks, they have to give serious thoughts to
their mechanisms and effects, especially when doctors' interests
in full information leave much to be desired.
»Brave New Psychiatry« consists of two volumes,
which are enclosed particularly.
Peter Lehmann: "Brave New Psychiatry",
Vol. 1: "Wie Chemie und Strom auf Geist und Psyche wirken"
(= "How chemistry and electricity work on mind and psyche"),
E-Book. See
full information at www.antipsychiatrieverlag.de/snp1.htm
English
language order form for orders directly at Peter Lehmann Publishing
/ German
language order form
In the centre of attention in this volume are the many and diverse
risks and damages in the psychic and mental system. Main topics
are: drug-caused emotional impoverishment, changing of the personality,
depression, desperation, suicide, confusion, delirium and psychotic
states; disturbances of the senses, memory, concentration, sleep
and dreams; self-trials of doctors; animal experiments.
In a special chapter
Leonard Roy Frank, the US-American expert on damages of electroshocks, shows the
negative effects (especially loss of memory) of this disputed method.
With an extensive register and 1102 sources from all over the
world.
Peter Lehmann: "Brave New Psychiatry",
Vol. 2 "Wie Psychopharmaka den Körper verändern"
(= "How psychiatric drugs change the body"). Ebook.
See
full information at www.antipsychiatrieverlag.de/snp2.htm
English
language order form for orders directly at Peter Lehmann Publishing
/ German
language order form
In the centre of attention here are the psychiatric drugs' short-term,
medium-term and long-term risks and damages, which find expression
in the muscle and autonomic system, for example aspartly
life-dangerousmuscle-cramps, movement-disorders, genetic
damages, harms to the liver, heart and sexual-organs.
A chapter
by its own is dedicated to the potential of dependence on theses substances. Its
special status is caused by the fact, that their administratorswith the
exception of tranquilizersdeny their potential of dependence. They conceal
possible withdrawal-symptoms, rebound-phenomenons, supersensibility-reactions
of the receptors as well as possible irreversible drug damages and change the
definitions into symptoms-alteration: for example chronic anxiety after long-term
administration of antidepressants or tranquilizers, states of confusion after
withdrawal from lithium and chronic psychosis after administration of neuroleptics.
Prudent advices, how the risk of relapse can be reduced and how withdrawal-effects
can be mitigated, balance this volume.
With an extensive register, too, and 1677 sources from all over
the world.